Eton Pharmaceuticals, Inc. Quarterly Operating Margin in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q3 2020 to Q3 2024.
  • Eton Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2024 was -15.1 %, a 365% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Operating Margin for 2023 was -3.77 %, a 90.3% increase from 2022.
  • Eton Pharmaceuticals, Inc. annual Operating Margin for 2022 was -38.9 %, a 468% decline from 2021.
  • Eton Pharmaceuticals, Inc. annual Operating Margin for 2021 was -6.85 %, a 100% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -15.1 -20.7 -365% Jul 1, 2024 Sep 30, 2024
Q2 2024 -20 -18.3 -1099% Apr 1, 2024 Jun 30, 2024
Q1 2024 1.58 +25 Jan 1, 2024 Mar 31, 2024
Q4 2023 -3.77 +35.1 +90.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 5.68 +48.2 Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.67 +65.2 +97.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -23.4 +75.2 +76.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -38.9 -32 -468% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42.5 +22.2 +34.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -66.8 +4.76 +6.65% Apr 1, 2022 Jun 30, 2022
Q1 2022 -98.6 +10.1 +9.26% Jan 1, 2022 Mar 31, 2022
Q4 2021 -6.85 +69.5K +100% Oct 1, 2021 Dec 31, 2021
Q3 2021 -64.7 +5.29K +98.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -71.6 Apr 1, 2021 Jun 30, 2021
Q1 2021 -109 Jan 1, 2021 Mar 31, 2021
Q4 2020 -69.5K Oct 1, 2020 Dec 31, 2020
Q3 2020 -5.36K Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.